Widening gap in age at muscular dystrophy-associated death between blacks and whites, 1986-2005

Neurology

Volumn 75, Issue 11, 2010, Pages 982-989

  Kenneson, Aileen ^a   Vatave, Ajay ^a   Finkel, Richard ^b  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b Division of Neurology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGE; ARTICLE; CARDIOMYOPATHY; CHILD; COMORBIDITY; DEATH; DISEASE COURSE; ENVIRONMENTAL FACTOR; EUROPEAN AMERICAN; FEMALE; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HEALTH DISPARITY; HEREDITY; HUMAN; INCIDENCE; LUNG INFECTION; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCULAR DYSTROPHY; PRIORITY JOURNAL; SOCIOECONOMICS; TREND STUDY; UNITED STATES; BLACK PERSON; CAUCASIAN; COMPLICATION; EPIDEMIOLOGY; MUSCULAR DYSTROPHIES; SEX DIFFERENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CARDIOMYOPATHIES; CHILD; COMORBIDITY; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MUSCULAR DYSTROPHIES; SEX FACTORS; UNITED STATES; YOUNG ADULT;

EID: 77957267994     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181f25e5b     Document Type: Article

References (34)

1. Emery AE. The muscular dystrophies. Lancet 2002;359: 687-695.
2. Aberion G, Alba A, Lee MH, Solomon M. Pulmonary care of Duchenne type of muscular dystrophy. NY State J Med 1973;73:1206-1207.
3. Alexander MA, Johnson EW, Petty J, Stauch D. Mechanical ventilation of patients with late stage Duchenne muscular dystrophy: management in the home. Arch Phys Med Rehabil 1979;60:289-292.
4. Bach J, Alba A, Pilkington LA, Lee M. Long-term rehabilitation in advanced stage of childhood onset, rapidly progressive muscular dystrophy. Arch Phys Med Rehabil 1981;62:328-331.
5. Curran FJ, Colbert AP. Ventilator management in Duch-enne muscular dystrophy and postpoliomyelitis syndrome: twelve years' experience. Arch Phys Med Rehabil 1989;70: 180-185.
6. Eagle M, Bourke J, Bullock R, et al. Managing Duchenne muscular dystrophy: the additive effect of spinal surgery and home nocturnal ventilation in improving survival. Neuromuscul Disord 2007;17:470-475.
7. Markham LW, Kinnett K, Wong BL, Woodrow Benson D, Cripe LH. Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy. Neuromuscul Disord 2008;18:365-370.
8. Simonds AK. Recent advances in respiratory care for neu-romuscular disease. Chest 2006;130:1879-1886.
9. Bach JR, O'Brien J, Krotenberg R, Alba AS. Management of end stage respiratory failure in Duchenne muscular dystrophy. Muscle Nerve 1987;10:177-182.
10. Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Dis-ord 2002;12:926-929.
11. Yasuma F, Konagaya M, Sakai M, Kuru S, Kawamura T. A new lease on life for patients with Duchenne muscular dystrophy in Japan. Am J Med 2004;117:363.
12. Manzur AY, Kuntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Co-chrane Database Syst Rev 2008;1:CD003725.
13. Biggar WD, Harris VA, Eliasoph L, Alman B. Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscul Disord 2006;16:249-255.
14. Silversides CK, Webb GD, Harris VA, Biggar DW. Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy. Am J Cardiol 2003;91: 769-772.
15. Kenneson A, Kolor K, Yang Q, Olney RS, Rasmussen SA, Friedman JM. Trends and racial disparities in muscular dystrophy deaths in the United States, 1983-1998: an analysis of multiple cause mortality data. Am J Med Genet A 2006;140:2289-2297.
16. AHRQ. National Healthcare Disparities Report. Rock-ville, MD: Agency for Healthcare Research and Quality; 2005.
17. Mukamel DB, Weimer DL, Buchmueller TC, Ladd H, Mushlin AI. Changes in racial disparities in access to coronary artery bypass grafting surgery between the late 1990s and early 2000s. Med Care 2007;45:664-671.
18. Shen JJ, Washington EL, Chung K, Bell R. Factors underlying racial disparities in hospital care of congestive heart failure. Ethn Dis 2007;17:206-213.
19. CDC. 2006 Disability and Health State Chartbook: Profiles of Health for Adults With Disabilities. Atlanta: Centers for Disease Control and Prevention 2006.
20. Nigro G, Comi LI, Politano L, Bain RJ. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 1990;26:271-277.
21. Nigro G, Comi LI, Politano L, et al. Evaluation of the cardiomyopathy in Becker muscular dystrophy. Muscle Nerve 1995;18:283-291.
22. Sanna T, Dello Russo A, Toniolo D, et al. Cardiac features of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutations. Eur Heart J 2003;24:2227-2236.
23. Finsterer J, Stollberger C. Cardiac involvement in Becker muscular dystrophy. Can J Cardiol 2008;24: 786-792.
24. CDC Wonder: Multiple Cause of Death, 1999-2004. Rockville, MD: Health and Human Services. Available at: http://wonder.cdc.gov/mcd.html. Accessed July 14, 2009.
25. Israel RA, Rosenberg HM, Curtin LR. Analytical potential for multiple cause-of-death data. Am J Epidemiol 1986; 124:161-179.
26. WHO. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, Based on the Recommendations of the Ninth Revision Conference 1975. Geneva: World Health Organization 1977.
27. WHO. International Statistical Classification of Diseases and Health Related Problems, ICD-10. Geneva: World Health Organization; 2000.
28. Rosenberg HM, Maurer JD, Sorlie PD, et al. Quality of death rates by race and Hispanic origin: a summary of current research, 1999. Vital Health Stat 2 1999;128:1-13.
29. Gibson B. Long-term ventilation for patients with Duch-enne muscular dystrophy: physicians' beliefs and practices. Chest 2001;119:940-946.
30. Caveney AF, Smith MA, Morgenstern LB, Lisabeth LD. Use of death certificates to study ethnic-specific mortality. Public Health Rep 2006;121:275-281.
31. Poe GS, Powell-Griner E, McLaughlin JK, Placek PJ, Thompson GB, Robinson K. Comparability of the death certificate and the 1986 National Mortality Fol-lowback Survey. Vital Health Stat 2 1993;118: 1-53.
32. Boyle CA, Decoufle P. National sources of vital status information: extent of coverage and possible selectivity in reporting. Am J Epidemiol 1990;131:160-168.
33. Lloyd-Jones DM, Martin DO, Larson MG, Levy D. Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med 1998;129:1020-1026.
34. Miller LA, Romitti PA, Cunniff C, et al. The Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology. Birth Defects Res A Clin Mol Teratol 2006;76:793-797.